MedPath

Performance Assessment of a Modified Daily Disposable Contact Lens

Not Applicable
Completed
Conditions
Refractive Errors
Myopia
Hyperopia
Registration Number
NCT03762668
Lead Sponsor
Alcon Research
Brief Summary

The purpose of this study is to compare visual acuity between two daily disposable contact lenses.

Detailed Description

The expected duration of subject participation in the study is approximately 2 weeks, with 3 scheduled visits.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
62
Inclusion Criteria
  • Able to understand and sign an approved Informed Consent form;
  • Current wearer of commercial DAILIES TOTAL1 Contact Lenses in both eyes;
  • Other protocol-specified inclusion criteria may apply.
Exclusion Criteria
  • Any eye condition that contraindicates contact lens wear, as determined by the Investigator;
  • Any eye surgery that contraindicates contact lens wear, as determined by the Investigator;
  • Wears habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week)
  • Monocular (only one eye with functional vision);
  • Other protocol-specified exclusion criteria may apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
High Contrast Distance Visual Acuity (logMAR)Day 1 Dispense, Day 7 Follow-Up

Distance visual acuity (VA) testing was performed using letter charts. Each row of the chart contained 5 letters, with the letters on each row progressively smaller than the row above. The subject read the letters from larger to smaller. The test terminated when the subject either misidentified a majority of letters on 1 row or progressed to the smallest row of letters. Visual acuity scoring sheets were used to record the number of letters correctly read. LogMAR VA was calculated based on the total number of letters read incorrectly as follows: LogMAR Acuity = base reading + (0.02 x number of letters missed). A lower logMAR value indicates better VA.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Alcon Investigative Site

🇺🇸

Memphis, Tennessee, United States

Alcon Investigative Site
🇺🇸Memphis, Tennessee, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.